Skip to main content
. Author manuscript; available in PMC: 2021 Dec 21.
Published in final edited form as: Anticancer Res. 2021 Sep 1;41(9):4215–4228. doi: 10.21873/anticanres.15226

Figure 5.

Figure 5.

Western blots and densitometric analysis of p-EGFR and p-MET in rociletinib resistant H1975 xenograft model of lung cancer. Data are representative of three different experiments and presented as mean, and error bars refer to SEM. ***p<0.001 was considered significant when compared to control. MET: MET proto-oncogene, receptor tyrosine kinase; EGFR: epidermal growth factor receptor.